PHRM — Pharmather Holdings Share Price
Last trade - 00:00- CA$19.03m
- CA$17.48m
- 52
- 12
- 54
- 33
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 11.98 | ||
| Price to Tang. Book | 11.98 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -93.96% | ||
| Return on Equity | -63.77% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st May | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | 27.6 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases. The Company is in the development of programs for the delivery of KETARX (ketamine) in a patch and on-body pump for mental health, pain and medical countermeasures indications.
Directors
- Last Annual
- May 31st, 2024
- Last Interim
- November 30th, 2024
- Incorporated
- March 20th, 2019
- Public Since
- October 9th, 2020
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 88,519,065
- Address
- 82 Richmond Street East, TORONTO, M5C 1P1
- Web
- https://www.pharmather.com/
- Phone
- Auditors
- CLEARHOUSE LLP
Upcoming Events for PHRM
Similar to PHRM
1933 Industries
Canadian Securities Exchange
1CM
Canadian Securities Exchange
Adastra Holdings
Canadian Securities Exchange
Aion Therapeutic
Canadian Securities Exchange
Asia Green Biotechnology
Canadian Securities Exchange
FAQ
As of Today at 22:37 UTC, shares in Pharmather Holdings are trading at CA$0.22. This share price information is delayed by 15 minutes.
Shares in Pharmather Holdings last closed at CA$0.22 and the price had moved by -2.27% over the past 365 days. In terms of relative price strength the Pharmather Holdings share price has underperformed the Toronto Stock Exchange 300 Composite Index by -11.91% over the past year.
The overall consensus recommendation for Pharmather Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out morePharmather Holdings does not currently pay a dividend.
Pharmather Holdings does not currently pay a dividend.
Pharmather Holdings does not currently pay a dividend.
To buy shares in Pharmather Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.22, shares in Pharmather Holdings had a market capitalisation of CA$19.03m.
Here are the trading details for Pharmather Holdings:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: PHRM
Based on an overall assessment of its quality, value and momentum Pharmather Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Pharmather Holdings is CA$5.00. That is 2225.58% above the last closing price of CA$0.22.
Analysts covering Pharmather Holdings currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.10 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmather Holdings. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -24.24%.
As of the last closing price of CA$0.22, shares in Pharmather Holdings were trading -3.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Pharmather Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Pharmather Holdings' directors